Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.06 USD | -2.13% | -4.76% | -13.76% |
03/05 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating | MT |
02/05 | Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024 |